These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22728049)

  • 1. Targeting pancreatic cancer stem cells for cancer therapy.
    Xia J; Chen C; Chen Z; Miele L; Sarkar FH; Wang Z
    Biochim Biophys Acta; 2012 Dec; 1826(2):385-99. PubMed ID: 22728049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
    Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
    Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition.
    Miyazaki Y; Matsubara S; Ding Q; Tsukasa K; Yoshimitsu M; Kosai K; Takao S
    Mol Cancer; 2016 Jun; 15(1):49. PubMed ID: 27349387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.
    Ponnurangam S; Dandawate PR; Dhar A; Tawfik OW; Parab RR; Mishra PD; Ranadive P; Sharma R; Mahajan G; Umar S; Weir SJ; Sugumar A; Jensen RA; Padhye SB; Balakrishnan A; Anant S; Subramaniam D
    Oncotarget; 2016 Jan; 7(3):3217-32. PubMed ID: 26673007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Cancer Stem Cells for Chemoprevention of Pancreatic Cancer.
    Subramaniam D; Kaushik G; Dandawate P; Anant S
    Curr Med Chem; 2018; 25(22):2585-2594. PubMed ID: 28137215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer.
    Mueller MT; Hermann PC; Witthauer J; Rubio-Viqueira B; Leicht SF; Huber S; Ellwart JW; Mustafa M; Bartenstein P; D'Haese JG; Schoenberg MH; Berger F; Jauch KW; Hidalgo M; Heeschen C
    Gastroenterology; 2009 Sep; 137(3):1102-13. PubMed ID: 19501590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer stem cells: emerging target for designing novel therapy.
    Li Y; Kong D; Ahmad A; Bao B; Sarkar FH
    Cancer Lett; 2013 Sep; 338(1):94-100. PubMed ID: 22445908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling.
    Balic A; Sørensen MD; Trabulo SM; Sainz B; Cioffi M; Vieira CR; Miranda-Lorenzo I; Hidalgo M; Kleeff J; Erkan M; Heeschen C
    Mol Cancer Ther; 2014 Jul; 13(7):1758-71. PubMed ID: 24785258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.
    Takebe N; Harris PJ; Warren RQ; Ivy SP
    Nat Rev Clin Oncol; 2011 Feb; 8(2):97-106. PubMed ID: 21151206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer stem cells and EMT in drug resistance and metastasis.
    Sarkar FH; Li Y; Wang Z; Kong D
    Minerva Chir; 2009 Oct; 64(5):489-500. PubMed ID: 19859039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells.
    Barman S; Fatima I; Singh AB; Dhawan P
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
    Takebe N; Miele L; Harris PJ; Jeong W; Bando H; Kahn M; Yang SX; Ivy SP
    Nat Rev Clin Oncol; 2015 Aug; 12(8):445-64. PubMed ID: 25850553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of pancreatic cancer stem cells and their clinical and therapeutic implications.
    Gzil A; Zarębska I; Bursiewicz W; Antosik P; Grzanka D; Szylberg Ł
    Mol Biol Rep; 2019 Dec; 46(6):6629-6645. PubMed ID: 31486978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Finding and killing the CRABs of pancreatic cancer.
    Caldwell ME; Tuveson DA
    Gastroenterology; 2009 Sep; 137(3):782-5. PubMed ID: 19643193
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
    Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
    Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin-Notch signaling axis is involved in pancreatic cancer progression.
    Harbuzariu A; Rampoldi A; Daley-Brown DS; Candelaria P; Harmon TL; Lipsey CC; Beech DJ; Quarshie A; Ilies GO; Gonzalez-Perez RR
    Oncotarget; 2017 Jan; 8(5):7740-7752. PubMed ID: 27999190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise Review: Stem Cells in Pancreatic Cancer: From Concept to Translation.
    Raj D; Aicher A; Heeschen C
    Stem Cells; 2015 Oct; 33(10):2893-902. PubMed ID: 26202953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
    Laranjeira AB; Yang SX
    Expert Opin Drug Discov; 2016 Nov; 11(11):1071-1080. PubMed ID: 27626707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways.
    Oren O; Smith BD
    Stem Cell Rev Rep; 2017 Feb; 13(1):17-23. PubMed ID: 27730468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.
    Tanase CP; Neagu AI; Necula LG; Mambet C; Enciu AM; Calenic B; Cruceru ML; Albulescu R
    World J Gastroenterol; 2014 Aug; 20(31):10790-801. PubMed ID: 25152582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.